Pulmonary · Topic 24 of 28
Tuberculosis
Tuberculosis
Isolate first, then three sputa: active TB gets four drugs for 2 months and two drugs for 4 more; latent TB gets a short rifamycin course.
Place suspected pulmonary TB in airborne isolation — a negative-pressure room with 6–12 air changes per hour — and wear a fit-tested N95 (or higher) respirator, not a surgical mask, to enter.
Collect ≥ 3 sputum specimens 8–24 hours apart (≥ 1 early-morning) for AFB smear and mycobacterial culture, with NAAT on at least one; a positive NAAT generally confirms TB, and culture gives susceptibilities.
Drug-susceptible TB: isoniazid, rifampin, pyrazinamide and ethambutol for a 2-month intensive phase, then isoniazid plus rifampin for a 4-month continuation phase (6 months total). Stop ethambutol once the isolate is pan-susceptible.
Diagnosis & monitoring
Work-upDo right now
In this orderWhy each step
Management
OrdersRed flags & don'ts
Avoid harmThe rules
Know theseLatent TB infection or active TB?
Commonly confused| Symptoms | None |
|---|---|
| TST or IGRA | Positive |
| Chest imaging and sputum | No active disease; sputum not needed |
| Contagious | No |
| Treatment | 3HP, 4R or 3HR |
More detail
ReferenceShow 7 reference facts
Latent TB is infection without disease — not contagious; active pulmonary TB spreads by air until effective therapy takes hold.
Sources · Merck Manual Professional — Tuberculosis (TB) · Saukkonen JJ et al. Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. Am J Respir Crit Care Med 2025 · CDC — Treatment for Latent Tuberculosis Infection (clinical guidance) · CDC — Tuberculin Skin Test (clinical testing guidance) · Saukkonen JJ et al. An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy. Am J Respir Crit Care Med 2006;174:935–952 · Starter sheet built from the verified AGACNP fact map (facts reviewed 2026-10-15).